retatrutide approval timeline FDA Status 2026: Everything We Know So Far Retatrutide UK | The Ultimate

Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023

Other factors, including drop-out rates due to GI AEs, use of anti-emetics or other rescue therapies, specific dosing regimens (e.g., semaglutides approved doses of 0.51.0 mg for T2D vs

I went from about 250 pounds back up to over 300 pounds

Neutral Effect of Exenatide on Serum Testosterone in Men With Type 2 Diabetes Mellitus: A Prospective Cohort